• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对1型人类免疫缺陷病毒感染的中和抗体反应的快速演变。

Rapid evolution of the neutralizing antibody response to HIV type 1 infection.

作者信息

Richman Douglas D, Wrin Terri, Little Susan J, Petropoulos Christos J

机构信息

Department of Pathology, Veterans Affairs San Diego Healthcare System and the University of California at San Diego, La Jolla, CA 92093-0679, USA.

出版信息

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9. doi: 10.1073/pnas.0630530100. Epub 2003 Mar 18.

DOI:10.1073/pnas.0630530100
PMID:12644702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC153062/
Abstract

A recombinant virus assay was used to characterize in detail neutralizing antibody responses directed at circulating autologous HIV in plasma. Examining serial plasma specimens in a matrix format, most patients with primary HIV infection rapidly generated significant neutralizing antibody responses to early (0-39 months) autologous viruses, whereas responses to laboratory and heterologous primary strains were often lower and delayed. Plasma virus continually and rapidly evolved to escape neutralization, indicating that neutralizing antibody exerts a level of selective pressure that has been underappreciated based on earlier, less comprehensive characterizations. These data argue that neutralizing antibody responses account for the extensive variation in the envelope gene that is observed in the early months after primary HIV infection.

摘要

采用重组病毒检测法详细表征针对血浆中循环自体HIV的中和抗体反应。以矩阵形式检测系列血浆样本,大多数原发性HIV感染患者迅速产生针对早期(0 - 39个月)自体病毒的显著中和抗体反应,而针对实验室毒株和异源原发性毒株的反应往往较低且延迟。血浆病毒持续快速进化以逃避中和,这表明中和抗体施加了一定程度的选择压力,而基于早期不太全面的表征,这种压力一直未得到充分认识。这些数据表明,中和抗体反应解释了原发性HIV感染后最初几个月包膜基因中观察到的广泛变异。

相似文献

1
Rapid evolution of the neutralizing antibody response to HIV type 1 infection.对1型人类免疫缺陷病毒感染的中和抗体反应的快速演变。
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9. doi: 10.1073/pnas.0630530100. Epub 2003 Mar 18.
2
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.1型人类免疫缺陷病毒感染个体初次血清转化后的自体和异体中和抗体反应。
J Virol. 1997 May;71(5):3734-41. doi: 10.1128/JVI.71.5.3734-3741.1997.
3
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.急性与慢性人类免疫缺陷病毒(HIV)感染中针对自体和异源病毒的中和抗体反应:关于HIV完全逃避中和抗体反应能力受限的证据
J Virol. 2006 Jun;80(12):6155-64. doi: 10.1128/JVI.00093-06.
4
Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.非保护性疫苗接种对后续人类免疫缺陷病毒感染抗体反应的影响。
J Clin Invest. 1994 Jan;93(1):140-6. doi: 10.1172/JCI116937.
5
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
6
Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.由HIV-1感染患者腮腺IgA介导的1型人类免疫缺陷病毒(HIV-1)中和作用。
J Infect Dis. 2000 May;181(5):1607-13. doi: 10.1086/315420. Epub 2000 May 8.
7
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.在近期的HIV感染过程中,中和抗体反应推动了1型人类免疫缺陷病毒包膜的演变。
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18514-9. doi: 10.1073/pnas.0504658102. Epub 2005 Dec 9.
8
Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.人类免疫缺陷病毒1型感染期间的中和抗体反应:类型和组特异性以及病毒逃逸
J Gen Virol. 1993 May;74 ( Pt 5):855-63. doi: 10.1099/0022-1317-74-5-855.
9
Multivariate analysis of human immunodeficiency virus type 1 neutralization data.人类免疫缺陷病毒1型中和数据的多变量分析。
J Virol. 1996 Sep;70(9):6235-43. doi: 10.1128/JVI.70.9.6235-6243.1996.
10
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.1型人类免疫缺陷病毒的V1-V2包膜环序列在感染过程中会扩展并增加糖基化位点,这些修饰会影响抗体中和敏感性。
J Virol. 2006 Oct;80(19):9586-98. doi: 10.1128/JVI.00141-06.

引用本文的文献

1
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.接受抗逆转录病毒治疗的儿童与成人中HIV-1前病毒的差异缺陷
Viruses. 2025 Jul 9;17(7):961. doi: 10.3390/v17070961.
2
Phylogenetics and molecular evolution to understand and curb the HIV pandemic.利用系统发育学和分子进化来理解和遏制艾滋病大流行。
Nat Rev Microbiol. 2025 Jun 30. doi: 10.1038/s41579-025-01202-w.
3
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.接受抗逆转录病毒治疗的儿童与成人中HIV-1前病毒的差异缺陷
bioRxiv. 2025 May 27:2025.05.23.655786. doi: 10.1101/2025.05.23.655786.
4
Future of bNAbs in HIV Treatment.HIV治疗中广谱中和抗体的未来。
Curr HIV/AIDS Rep. 2025 May 27;22(1):34. doi: 10.1007/s11904-025-00744-1.
5
Activation of CXCR3 Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development.急性HIV-1感染期间淋巴结中CXCR3辅助性滤泡T细胞和B细胞的激活与HIV特异性抗体的产生相关。
J Virol. 2025 Mar 18;99(3):e0153224. doi: 10.1128/jvi.01532-24. Epub 2025 Feb 11.
6
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.在HIV-1包膜构象可塑性的背景下评估广谱中和抗体(bnAb)的效力。
PLoS Pathog. 2025 Jan 21;21(1):e1012825. doi: 10.1371/journal.ppat.1012825. eCollection 2025 Jan.
7
Current methods for detecting and assessing HIV-1 antibody resistance.检测和评估HIV-1抗体耐药性的当前方法。
Front Immunol. 2025 Jan 6;15:1443377. doi: 10.3389/fimmu.2024.1443377. eCollection 2024.
8
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.在急性至慢性HIV-1感染过程中,Nef在拮抗SERINC5方面的功能变异性。
AIDS. 2025 Mar 1;39(3):229-240. doi: 10.1097/QAD.0000000000004079. Epub 2024 Dec 4.
9
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.在 ENSEMBLE 单剂量 Ad26.COV2.S 疫苗功效试验中,针对严重/危重症 COVID-19 的中和抗体保护相关因素。
Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y.
10
HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond.在早期抗逆转录病毒治疗(ART)及之后,从循环 T 细胞亚群中获得的病毒储存库中 HIV-1 的多样性。
PLoS Pathog. 2024 Sep 18;20(9):e1012526. doi: 10.1371/journal.ppat.1012526. eCollection 2024 Sep.

本文引用的文献

1
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.HIV-1通过受体结合位点的构象掩盖来逃避抗体介导的中和作用。
Nature. 2002 Dec 12;420(6916):678-82. doi: 10.1038/nature01188.
2
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies.在高滴度中和抗体被动转移后,确定血浆中具有统计学意义的中和滴度,该滴度可提供针对猿猴 - 人类免疫缺陷病毒攻击的保护作用。
J Virol. 2002 Mar;76(5):2123-30. doi: 10.1128/jvi.76.5.2123-2130.2002.
3
Evolutionary and immunological implications of contemporary HIV-1 variation.当代HIV-1变异的进化和免疫学意义
Br Med Bull. 2001;58:19-42. doi: 10.1093/bmb/58.1.19.
4
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.抗体在体外血清水平完全中和的情况下,可保护猕猴免受致病性R5猿猴/人类免疫缺陷病毒的阴道攻击。
J Virol. 2001 Sep;75(17):8340-7. doi: 10.1128/jvi.75.17.8340-8347.2001.
5
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.用针对口服猿猴-人免疫缺陷病毒攻击的三种人单克隆抗体的三联组合对新生猕猴进行产后被动免疫。
J Virol. 2001 Aug;75(16):7470-80. doi: 10.1128/JVI.75.16.7470-7480.2001.
6
The antiviral activity of antibodies in vitro and in vivo.抗体在体外和体内的抗病毒活性。
Adv Immunol. 2001;77:195-262. doi: 10.1016/s0065-2776(01)77018-6.
7
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.对HIV-1的中和抗体反应:病毒逃避和摆脱体液免疫。
AIDS. 1999;13 Suppl A:S137-62.
8
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.一种针对1型人类免疫缺陷病毒的新型表型药物敏感性检测方法。
Antimicrob Agents Chemother. 2000 Apr;44(4):920-8. doi: 10.1128/AAC.44.4.920-928.2000.
9
Viral dynamics of acute HIV-1 infection.急性HIV-1感染的病毒动力学
J Exp Med. 1999 Sep 20;190(6):841-50. doi: 10.1084/jem.190.6.841.
10
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.通过中和抗体的被动转移保护猕猴免受致病性猿猴/人类免疫缺陷病毒89.6PD的侵害。
J Virol. 1999 May;73(5):4009-18. doi: 10.1128/JVI.73.5.4009-4018.1999.